ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Agrees: Three Dyes, Hair Color Agent Are Carcinogens; Risk To Humans – Brown

May 5, 1978

Oral Contraceptives Related To Liver Tumors; New Studies Urged

March 12, 1976

Oblimersen Combination Improves CLL Survival

December 28, 2007

NCI’s Supercomputer Undergoing Testing

April 11, 1986

Cooperative Group Chairmen Unhappy Over Contracts They Missed, NCI Protocol Review

January 13, 1978

Advisors Say 10 Percent Payline “Not Tenable;” All NCI Programs Must Share Budget Cuts.

March 31, 2006